Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study
Authors:
- Shannon N. WestinSWShannon N. Westin
- Michael W. SillMSMichael W. Sill
- Robert L. ColemanRCRobert L. Coleman
- Steven WaggonerSWSteven Waggoner
- Kathleen N. MooreKMKathleen N. Moore
- Cara A. MathewsCMCara A. Mathews
- Lainie P. MartinLMLainie P. Martin
- Susan C. ModesittSMSusan C. Modesitt
- Sanghoon LeeSLSanghoon Lee
- Zhenlin JuZJZhenlin Ju
- Gordon B. MillsGMGordon B. Mills
- Russell J. SchilderRSRussell J. Schilder
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 155 (3) , 420-428
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
This publication has 39 references indexed in Scilit:
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancerGenome Research, 2012
- Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer CellsCancer Cell, 2012
- High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein StabilityCancer Discovery, 2011
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensationTrends in Biochemical Sciences, 2011
- Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimusJournal of Clinical Investigation, 2010
- The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomasBritish Journal of Cancer, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancersNature Medicine, 2008
- Exploiting the PI3K/AKT Pathway for Cancer Drug DiscoveryNature Reviews Drug Discovery, 2005